Orphan Drugs in Development for the Treatment of Small-Cell Lung Cancer: Emerging Data on Lurbinectedin

Overview of attention for article published in Lung Cancer: Targets and Therapy, March 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#14 of 128)
Good Attention Score compared to outputs of the same age (78th percentile)

Mentioned by

twitter: 8 X users

patent: 1 patent

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Patents Dimensions citations

So far, Dimensions has found 10 publications that cite this research output.

10

The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.

A Comprehensive Review on the Role of Lurbinectedin in Soft Tissue Sarcomas

Article in Current Treatment Options in Oncology (February 2024)

Recent advances in BCRP‐induced breast cancer resistance treatment with marine‐based natural products

Article in IUBMB Life (July 2023)

Chapter 2 Chemotherapy

Book chapter (January 2023)